You are here

insurers

Insurers Could Meet Sanders Halfway On Single-Payer Proposal With Medicare Advantage For All

Insurers Could Meet Sanders Halfway On Single-Payer Proposal With Medicare Advantage For All

Forbes

healthcare reform

Flag link:

Insurers, doctors battle over new heart disease drugs

Insurers, doctors battle over new heart disease drugs

CNBC

cardiovascular disease

PCSK9 inhibitors

Flag link:

FDA set to work with insurers, PBMs to fight opioid crisis

FDA set to work with insurers, PBMs to fight opioid crisis

Fierce Pharma

Flag link:

Medicare patients don’t share in drug discounts given insurers and PBMs

Medicare patients don’t share in drug discounts given insurers and PBMs

Stat

Flag link:

Amgen inks first money-back guarantee for Repatha

Amgen inks first money-back guarantee for Repatha

BioPharma Dive

Flag link:

How Trump’s First 100 Days Affected the Healthcare Industry

How Trump’s First 100 Days Affected the Healthcare Industry

Motley Fool

Express Scripts

Flag link:

Another US insurer places limits on Spinraza coverage

Another US insurer places limits on Spinraza coverage

BioPharma Dive

spinal muscular atrophy

Flag link:

Harris Poll: Only Nine Percent Of U.S. Consumers Believe Pharma And Biotechnology Put Patients Over Profits

Harris Poll: Only Nine Percent Of U.S. Consumers Believe Pharma And Biotechnology Put Patients Over Profits

TheStreet.com

pharma industry

Flag link:

Will Insurers Pay For Sarepta’s DMD Drug?

Will Insurers Pay For Sarepta’s DMD Drug?

Barron's

Duchenne Muscular Dystrophy

Flag link:

Appeals court overturns Stryker’s $9m win over insurer in Duracon Uni-Knee implants case

Appeals court overturns Stryker’s $9m win over insurer in Duracon Uni-Knee implants case

Mass Device

Duracon Uni-Knee

Flag link:

Insurers pay more for multiple sclerosis drug because rebates don’t help, report says

Insurers pay more for multiple sclerosis drug because rebates don’t help, report says

Stat/Pharmalot

multiple sclerosis

Flag link:

Another big insurer will pay for key drugs based on patient outcomes

Another big insurer will pay for key drugs based on patient outcomes

Stat

patient outcomes

Flag link:

Specialty Drugs Added $87 More To Each Enrollee's Tab, Blue Cross Says

Specialty Drugs Added $87 More To Each Enrollee's Tab, Blue Cross Says

Forbes

specialty medicines

Flag link:

Seven New York insurers end restrictions on coverage for hepatitis C drugs

Seven New York insurers end restrictions on coverage for hepatitis C drugs

BioPharma Dive

Gilead Sciences

Flag link:

US to pay more to insurers who provide Medicare Advantage in 2017

US to pay more to insurers who provide Medicare Advantage in 2017

Mass Device

Medicare Advantage

Flag link:

Insurers Don't Want to Pay for Pricey Cancer Meds

Insurers Don't Want to Pay for Pricey Cancer Meds

Motley Fool

Flag link:

Sanofi's Challenge: Unrestricted Insurance Coverage For MannKind's Afrezza

Sanofi's Challenge: Unrestricted Insurance Coverage For MannKind's Afrezza

Seeking Alpha

Flag link:

Pfizer CEO: Drug-pricing snafu isn't pharma's fault. It's insurers and their poor coverage

Pfizer CEO: Drug-pricing snafu isn't pharma's fault. It's insurers and their poor coverage

Fierce Pharma

Flag link:

2 major insurers draw lines in the sand for pricey PCSK9 coverage

2 major insurers draw lines in the sand for pricey PCSK9 coverage

BioPharma Dive

PCSK9 inhibitors

Flag link:

Vantage Point - U.S. Insurer Mergers Shrink Drug Buyer Pool

Vantage Point - U.S. Insurer Mergers Shrink Drug Buyer Pool

Seeking Alpha

Flag link: